Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Neuroone Medical Technologies (NMTC) Other Non-Current Assets (2016)

Neuroone Medical Technologies filings provide 2 years of Other Non-Current Assets readings, the most recent being $4277.0 for Q4 2016.

On a quarterly basis, Other Non-Current Assets rose 132.7% to $4277.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $4277.0, a 132.7% increase, with the full-year FY2016 number at $4277.0, up 132.7% from a year prior.
Other Non-Current Assets hit $4277.0 in Q4 2016 for Neuroone Medical Technologies, roughly flat from $4277.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $4277.0 in Q2 2016 to a low of $1838.0 in Q4 2015.